Common name
(3S,4S)-tetrahydrofuran-3,4-diol
IUPAC name
(3S,4S)-tetrahydrofuran-3,4-diol
SMILES
O1CC(C(C1)O)O
Common name
(3S,4S)-tetrahydrofuran-3,4-diol
IUPAC name
(3S,4S)-tetrahydrofuran-3,4-diol
SMILES
O1CC(C(C1)O)O
INCHI
InChI=1S/C4H8O3/c5-3-1-7-2-4(3)6/h3-6H,1-2H2/t3-,4-/m0/s1
FORMULA
C4H8O3
Common name
(3S,4S)-tetrahydrofuran-3,4-diol
IUPAC name
(3S,4S)-tetrahydrofuran-3,4-diol
Molecular weight
104.105
clogP
-0.109
clogS
0.954
Frequency
0.0010
HBond Acceptor
3
HBond Donor
2
Total PolarSurface Area
49.69
Number of Rings
1
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00503 | Inulin |
|
Diagnostic Agents; Tests for Renal Function and Ureteral Injuries; | Historically used in an important medical test of renal function, specifically a measure of glomerular filtration rate. Sometimes used to help relieve symptoms of diabetes mellitus - a condition characterised by hyperglycemia and/or hyperinsulinemia. |
| FDBD01299 | Ribostamycin |
|
Anti-Bacterial Agents; Aminoglycosides; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Aminoglycoside Antibacterials; | |
| FDBD01417 | Cangrelor |
|
Platelet Aggregation Inhibitors; Antithrombotic Agents; Blood and Blood Forming Organs; Platelet Aggregation Inhibitors Excl. Heparin; Purinergic P2Y Receptor Antagonists; | For use as an adjunct to percutaneous coronary intervention (PCI) for reducing the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients in who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor. |
3 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 1hp0_ligand_frag_1.mol2 | 1hp0 | 1 | -6.49 | C1[C@H]([C@H](CO1)O)O | 7 |
| 1ctu_ligand_frag_1.mol2 | 1ctu | 1 | -6.27 | C1OC[C@H]([C@H]1O)O | 7 |
| 1af2_ligand_frag_1.mol2 | 1af2 | 1 | -6.23 | C1OC[C@@H]([C@@H]1O)O | 7 |
| 2wr8_ligand_frag_5.mol2 | 2wr8 | 1 | -6.21 | C1OC[C@@H]([C@@H]1O)O | 7 |
| 4kxl_ligand_frag_3.mol2 | 4kxl | 1 | -6.21 | C1OC[C@H]([C@H]1O)O | 7 |
| 4kxm_ligand_frag_3.mol2 | 4kxm | 1 | -6.20 | C1OC[C@@H]([C@@H]1O)O | 7 |
| 1ctt_ligand_frag_1.mol2 | 1ctt | 1 | -6.19 | C1[C@@H]([C@@H](CO1)O)O | 7 |
| 2b1i_ligand_frag_1.mol2 | 2b1i | 1 | -6.19 | C1OC[C@H]([C@H]1O)O | 7 |
| 2xaf_ligand_frag_3.mol2 | 2xaf | 1 | -6.17 | C1OC[C@@H]([C@@H]1O)O | 7 |
| 1m9n_ligand_frag_1.mol2 | 1m9n | 1 | -6.16 | C1OC[C@@H]([C@@H]1O)O | 7 |
744 ,
75
